4D Molecular Therapeutics, Inc.FDMTNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 14 | 18↑32.5% | 3↓82.7% | 21↑562.3% | 0↓99.8% |
| Gross Profit | -39 | -43↓9.9% | -77↓78.0% | -76↑1.0% | 0↑100.0% |
| Operating Income | -57 | -71↓25.9% | -110↓54.3% | -113↓2.6% | -188↓66.4% |
| Net Income | -57 | -71↓25.8% | -107↓50.7% | -101↑6.2% | -161↓59.5% |
| EBITDA | -55 | -70↓26.4% | -108↓54.2% | -109↓1.0% | -181↓66.7% |
| EPS Diluted | -2.12 | -2.46↓16.0% | -3.12↓26.8% | -2.58↑17.3% | -2.98↓15.5% |